Pharmaceutical supply chains are among the most heavily regulated in Australia. Products must be stored by a NSW-licensed facility meeting Good Wholesaling and Good Distribution Practice. Every batch movement must be documented. Temperature-sensitive products need to be managed to validated conditions.
For international companies there is the added complexity of ARTG registration, Australian sponsorship and pharmacovigilance — roles DNH coordinates through specialist partners.